Successful concurrent chemoradiotherapy with cisplatin plus etoposide after incomplete resection for advanced thymic carcinoma

L Han, B Zhang, S Wu - Oxford Medical Case Reports, 2019 - academic.oup.com
The optimal therapy for advanced thymic carcinoma has long been controversial. Despite
that complete (R0) resection is recommend as the first-line treatment, multidisciplinary …

Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide followed by surgery for thymic carcinoma

H Kawasaki, N Taira, T Ichi, T Yohena… - European Journal of …, 2014 - Elsevier
Objective We present our experience treating the patients with thymic carcinoma using
induction chemotherapy according to weekly chemotherapy with cisplatin, vincristine …

Treatment and survival analyses of completely resected thymic carcinoma patients

Y Mao, S Wu - OncoTargets and therapy, 2015 - Taylor & Francis
Purpose To investigate the impact of chemotherapy and/or radiotherapy on disease-free
survival (DFS) and overall survival (OS) rates of patients with thymic carcinoma after …

Definitive IMRT for stage III thymic carcinoma: a brief report and literature review

SA Dooley, CM Anderson - Frontiers in oncology, 2016 - frontiersin.org
Introduction Thymic carcinoma is a rare malignancy often presenting at an advanced stage.
Radiation therapy and chemotherapy are often the only treatment options available to …

Paclitaxel and cisplatin with concurrent radiotherapy followed by surgery in locally advanced thymic carcinoma

M Fukuda, Y Obase, N Miyashita, Y Kobashi… - Anticancer …, 2007 - ar.iiarjournals.org
Thymic carcinoma is a rare neoplasm with a poor prognosis. We report the clinical course of
a patient who received complete surgical resection after effective induction treatment. A 72 …

Recent clinical experience with multimodality therapy in thymic carcinoma

J Huang, N Rizk, B Park, M Bains, R Flores… - Journal of Clinical …, 2007 - ascopubs.org
18003 Background: Thymic carcinomas typically carry a poor prognosis and are quite rare.
As such, their management has not been standardized. We reviewed our recent experience …

[HTML][HTML] A single-institution analysis of thymic carcinoma treated with multi-modality therapy

IH Mohiuddin, M Furqan, G Clamon… - Annals of radiation …, 2017 - ncbi.nlm.nih.gov
Purpose Review of our experience in treating thymic carcinoma patients using a
combination of surgery, chemotherapy and radiation therapy. Methods An institutional …

Multimodality treatment for advanced thymic carcinoma: outcomes of induction therapy followed by surgical resection in 16 cases at a single institution

Y Shintani, M Inoue, T Kawamura, S Funaki… - General thoracic and …, 2015 - Springer
Objective We reviewed our institutional experience with cases of multimodality treatment for
advanced thymic carcinoma to determine patient outcomes and prognostic indicators …

Successful multimodality treatment for locally advanced primary thymic adenocarcinoma: report of a case

T Haruki, M Wakahara, Y Taniguchi… - Journal of Surgical …, 2016 - academic.oup.com
Although the optimal treatment strategy for locally advanced thymic carcinomas has yet to be
determined, complete resection of the tumor after induction chemoradiotherapy (CRT) can …

[PDF][PDF] Concurrent chemoradiotherapy for unresectable thymic carcinoma

YY Chen, CH Huang, Y Tang… - Chang Gung Medical …, 2004 - cgmj.cgu.edu.tw
Background: Thymic carcinoma is a rare anterior mediastinal neoplasm. It is more invasive
and has a poorer prognosis than ordinary thymoma. Complete curative resection is …